Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Am J Gastroenterol. 2021 Dec 1;116(12):2446–2454. doi: 10.14309/ajg.0000000000001527

Table 4b:

Estimated acute pancreatitis rates per 1,000 patient-years from multivariable model* among subjects with some CFTR modulator use (n=1,795)

Pancreas Sufficient
Cystic Fibrosis (PS-CF)
Pancreas Insufficient
Cystic Fibrosis (PI-CF)
On CFTR Modulator, AP per 1000 patient years (95% CI) 4.65 (0.87, 24.78) 0.34 (0.08, 1.43)
Not on CFTR Modulator, AP per 1000 patient years (95% CI) 12.93 (3.47, 48.14) 0.67 (0.15, 3.02)
*

Adjusted for age (continuous)

Acute pancreatitis (AP)